Tissue Establishment and Cryobiology Unit, A Coruña University Hospital, A Coruña, Spain.
TRIP Foundation, Dutch office for hemo- and biovigilance, Leiden, the Netherlands.
Bone Marrow Transplant. 2023 Aug;58(8):842-848. doi: 10.1038/s41409-023-01982-w. Epub 2023 Apr 15.
Haematopoietic progenitor cell donation from bone marrow and mobilised peripheral blood obtained from related and unrelated donors is an established procedure. The donation process in general has proven to be safe, but in rare cases severe and even fatal events have been reported. The present study aimed at providing a description of the current situation of donor protection measures in Council of Europe member States. A specific questionnaire was developed to compile information on donation activities, graft sources, legal frameworks, donor protection measures, collection of donor outcome data, and long-term follow-up of paediatric and adult related and unrelated donors. The outcome of this survey served as a basis for elaborating the Recommendation CM/Rec(2020)6 of the Committee of Ministers to member States on establishing harmonised measures for the protection of haematopoietic progenitor cell donors.
从骨髓和动员的外周血中采集造血祖细胞供体来自于亲属和非亲属供体,这是一种已确立的程序。捐赠过程总体上被证明是安全的,但在极少数情况下,也有严重甚至致命的事件报告。本研究旨在描述欧洲委员会成员国中目前的供体保护措施现状。制定了一份专门的问卷,以收集有关捐赠活动、移植物来源、法律框架、供体保护措施、供体结果数据收集以及儿科和成人相关和非相关供体的长期随访的信息。该调查的结果为部长委员会向成员国提出关于制定造血祖细胞供体保护协调措施的建议 CM/Rec(2020)6 提供了依据。